CA
NZ
UK
AU
IND
US
Capricor Therapeutics, Inc. (NASDAQ: CAPR) was upgraded by B. Riley to Buy from Neutral, with the firm boosting its price target to $21 from $5.
Definium Therapeutics, Inc. (NASDAQ: DFTX) reported its second positive Phase 3 GAD study for DT120 ODT, with the Panorama trial meeting the Week 12 HAM-A primary endpoint at the 100 µg dose with a 5.1-point placebo-adjusted improvement and rapid onset by Day 2.
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) announced the FDA granted Breakthrough Therapy designation to intravenous AP-SA02 as an adjunctive therapy for complicated Staphylococcus aureus bacteremia, covering both MSSA and MRSA.
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) shares closed up 47% at $2.44 after the company terminated its PC111 option and license agreement with PinCell following a denied extension request.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) announced favorable Phase 1b CANYON-1 trial results evaluating once-daily oral CRB-913 for obesity, demonstrating statistically significant weight reduction across all cohort dosages.
Enovis (NYSE:ENOV) shares ticked higher in pre-market trading Tuesday, attempting to stabilize after a brutal past year that has seen the stock lose roughly 37% of its value. Enovis is a Wilmington, Delaware-based global medical technology company focused on clinically differentiated solutions for the …
Kestra Medical Technologies (NASDAQ:KMTS) shares fell sharply in pre-market trading Tuesday, extending Monday's after-hours slide, even as the company reported a strong topline beat in its fiscal first-quarter results. Kestra is a Kirkland, Washington-based commercial-stage wearable medical device and digital healthcare company focused on …
Eli Lilly (NYSE:LLY) shares rose in pre-market trading Tuesday after Berenberg upgraded the stock to Buy from Hold and lifted its price target to $1,400 from $1,220. The research firm's upgrade argues that the market is underestimating the value of Lilly's aggressive pipeline expansion, …
Tenet Healthcare (NYSE:THC) shares fell in pre-market trading Tuesday, pulling back from a strong multi-year run that took the stock to a 52-week high near $283 last week. Tenet is a Dallas, Texas-based diversified healthcare services company operating through Hospital Operations, Ambulatory Care, and …
Contineum Therapeutics (NASDAQ:CTNM) shares fell further in pre-market trading Tuesday, extending Monday's after-hours slide, after the company disclosed that its Phase 2 MOONLIGHT-1 trial did not meet its primary efficacy endpoint. Contineum is a San Diego, California-based clinical-stage biopharmaceutical company developing novel, oral small …
Please wait processing your request...